Lorrach, Germany

Nikola Obradovic

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bentley Innomed Gmbh. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nikola Obradovic. Retrieved from https://idiyas.com/inventor/nikola-obradovic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nikola Obradovic: Innovator in Medical Technology

Introduction

Nikola Obradovic is a notable inventor based in Lorrach, Germany. He has made significant contributions to the field of medical technology, particularly in the development of stent grafts. His innovative approach has led to advancements that enhance patient care and treatment options.

Latest Patents

Nikola Obradovic holds a patent for a stent graft that features a unique design. The stent graft comprises a stent with a plurality of ring segments arranged side by side, connected by connecting webs that have a meandering pattern. This design includes flexible tongues that are resiliently movable against the connecting webs, allowing for improved functionality. The membrane is clamped between the flexible tongues and the connecting webs, showcasing a novel approach to stent graft technology. He has 1 patent to his name.

Career Highlights

Nikola Obradovic is currently associated with Bentley Innomed GmbH, where he continues to work on innovative medical solutions. His expertise in the field has positioned him as a valuable asset to the company and the medical community.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Nikola Obradovic's contributions to medical technology, particularly through his patented stent graft design, highlight his role as an innovator in the field. His work continues to influence advancements in patient care and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…